Like Ozempic, Rybelsus is sometimes prescribed off-label for weight loss
Although studies were not designed to directly compare, the injectable form of the drug appears more effective than the pills
Some patients experience constipation due to prolonged transit time, while others may develop diarrhea, possibly related to changes in gut motility patterns or alterations in intestinal fluid handling
[1] [2] The medication works by binding to GLP-1 receptors in pancreatic beta cells, enhancing glucose-dependent insulin secretion, suppressing glucagon release, and slowing gastric emptying
Clinical trial data provides objective evidence about efficacy (24.2% weight loss at 48 weeks), safety (88.8% completion rate), side effects (peak at weeks 6-8, resolve by week 12 for most), and discontinuation outcomes (70-80% regain over 12-18 months, not immediately)
The review was triggered by the Icelandic medicines agency following reports of suicidal thoughts and self-injury in people using liraglutide and semaglutide medicines